DE69227089D1 - Weizen Alpha-Amylase-Inhibitor zur Behandlung von Diabetes - Google Patents

Weizen Alpha-Amylase-Inhibitor zur Behandlung von Diabetes

Info

Publication number
DE69227089D1
DE69227089D1 DE69227089T DE69227089T DE69227089D1 DE 69227089 D1 DE69227089 D1 DE 69227089D1 DE 69227089 T DE69227089 T DE 69227089T DE 69227089 T DE69227089 T DE 69227089T DE 69227089 D1 DE69227089 D1 DE 69227089D1
Authority
DE
Germany
Prior art keywords
alpha amylase
inhibitor used
amylase inhibitor
treat diabetes
wheat alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69227089T
Other languages
English (en)
Other versions
DE69227089T2 (de
Inventor
Hidehiko Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakurigaku Chuo Kenkyusho
Original Assignee
Yakurigaku Chuo Kenkyusho
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakurigaku Chuo Kenkyusho filed Critical Yakurigaku Chuo Kenkyusho
Application granted granted Critical
Publication of DE69227089D1 publication Critical patent/DE69227089D1/de
Publication of DE69227089T2 publication Critical patent/DE69227089T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69227089T 1991-11-18 1992-01-31 Weizen Alpha-Amylase-Inhibitor zur Behandlung von Diabetes Expired - Fee Related DE69227089T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3301684A JPH05139985A (ja) 1991-11-18 1991-11-18 糖尿病治療薬

Publications (2)

Publication Number Publication Date
DE69227089D1 true DE69227089D1 (de) 1998-10-29
DE69227089T2 DE69227089T2 (de) 1999-04-22

Family

ID=17899897

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69227089T Expired - Fee Related DE69227089T2 (de) 1991-11-18 1992-01-31 Weizen Alpha-Amylase-Inhibitor zur Behandlung von Diabetes

Country Status (4)

Country Link
EP (1) EP0543076B1 (de)
JP (1) JPH05139985A (de)
CA (1) CA2059840C (de)
DE (1) DE69227089T2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1045208C (zh) * 1993-09-24 1999-09-22 华北制药集团新药研究开发中心 异戊他定化合物、其制备方法及生产该化合物的微生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950319A (en) * 1970-01-29 1976-04-13 Farbenfabriken Bayer Aktiengesellschaft Amylase inhibitor from wheat gluten using alcohol
JPS61171431A (ja) * 1985-01-23 1986-08-02 Toyobo Co Ltd アミラ−ゼ阻害物質およびその製造法
US4910297A (en) * 1987-06-29 1990-03-20 Abi Biotechnology Inc. Alpha-amylase inhibitor
JP2757404B2 (ja) * 1988-12-09 1998-05-25 日清製粉株式会社 小麦からα−アミラーゼインヒビター含有物質を取得する方法
JP2757405B2 (ja) * 1988-12-09 1998-05-25 日清製粉株式会社 小麦から得られるα−アミラーゼインヒビターを含有するダイエット剤

Also Published As

Publication number Publication date
EP0543076B1 (de) 1998-09-23
DE69227089T2 (de) 1999-04-22
CA2059840A1 (en) 1993-05-19
EP0543076A2 (de) 1993-05-26
JPH05139985A (ja) 1993-06-08
EP0543076A3 (en) 1994-07-06
CA2059840C (en) 1995-08-29

Similar Documents

Publication Publication Date Title
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE59611411D1 (de) Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz
DE69227574D1 (de) Massnahmen zur Verbesserung von Verstärkern
DE69427869T2 (de) Botulinumtoxine zur behandlung von hyperhydrosis
DE69716647T2 (de) Biologische behandlung von gebrauchten kaustischen laugen
DE3689974D1 (de) Arzneimittel zur Behandlung von Emesis.
DE59609235D1 (de) Verwendung von aerogelen in der landwirtschaft
DE69412591D1 (de) Konservierung von blutplättchen
DE69212620D1 (de) Verwendung von Glycosaminoglycanen zur Behandlung von diabetischer Nephropathie und diabetischer Neuropathie
DE69312853D1 (de) Behandlung von Gummiartikeln
KR950704251A (ko) 프롤릴 엔도펩티다아제 억제 활성을 갖는 화합물 및 그 약학적 용도(compound with prolyl endopeptdase inhibitor activity and pharmaceutical use thereof)
DE69634951D1 (de) Topische verwendung von betulinsäure zur behandlung bösartiger melanome
DE69226763D1 (de) Härten von fluoroelastomeren
DE69316203D1 (de) Elektrochemische behandlung von oberflächen
DE69224173T2 (de) Behandlung von lignocellulosischen Materialien
DE68912685D1 (de) Reinigung von Glucosaminoglucan abbauenden Enzymen.
DE69814444D1 (de) Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation
DK73891D0 (da) Enzymbehandling
DE69221617D1 (de) Aufbereitung von flüssigkeit
DE59202663D1 (de) Verwendung eines UV-Strahlers zur Behandlung von Oberflächen.
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
DE68923219D1 (de) Behandlung von Abfällen.
ATE100826T1 (de) Behandlung von celluloseblaettern.
FI955165A0 (fi) 4-aryyli-4-hydroksi-tetrahydropyraanit ja 3-aryyli-3-hydroksi-tetrahydrofuraanit 5-lipoksygenaasi inhibiittoreina
DE69216089D1 (de) Behandlung von aluminiumblechen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee